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Edited by Ivan SadowskiAbstract Zic2 is a transcriptional activator that plays a crucial
role in mammalian forebrain development. It activates the tran-
scription of target genes by DNA binding and recruitment of
RNA helicase A (RHA). We recently reported that the Zic2–
RHA interaction is decreased by phosphatase treatment
in vitro. We have now identiﬁed the phosphorylation site (serine
200) in mouse Zic2. Zic2S200A was defective in RHA-binding,
and its transcriptional activation ability was diminished. These
data indicate that Zic2S200 is a target for phosphorylation by
DNA-dependent protein kinase, regulating Zic2-mediated tran-
scriptional activation.
 2007 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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Zic family proteins play critical roles in animal development
[1,2]. They are found in many eumetazoa, sharing highly con-
served ﬁve C2H2 zinc ﬁnger (ZF) motifs [3]. Zic2 mutations
cause holoprosencephaly (HPE), a medial forebrain defect, in
both human and mouse [4,5]. Zinc ﬁnger protein of cerebellum
2 (Zic2) can activate the transcription of several genes [6]. The
ZF domain binds DNA, recognizing GC-rich target sequences
[6], and is characterized as a transcriptional activation domain,
together with Zic-Opa-conserved (ZOC) an N-terminally
located evolutionally conserved domain [1,7].
In a previous study, we identiﬁed two types of Zic2-contain-
ing molecular complexes [8]. Complex I contains DNA-depen-
dent protein kinase catalytic subunit (DNA-PKcs), Ku70/80,
and poly(ADP-ribose) polymerase (PARP). Complex II con-
tains Ku70/80 and RNA helicase A (RHA). All components
interact directly with the Zic2 ZF domain. DNA-PKcs plays
important roles in non-homologous end-joining, V(D)J recom-
bination and transcriptional regulation [9–11]. Its serine/threo-
nine kinase activity is involved in phosphorylation of various
transcriptional factors and RNA polymerase II in vitro [11–
20]. RHA is an ATPase/double-stranded DNA/RNA helicaseAbbreviations: Zic2, zinc ﬁnger protein of cerebellum 2; RHA, RNA
helicase A; DNA-PK, DNA-dependent protein kinase; DNA-PKcs,
DNA-PK catalytic subunit; PARP, poly(ADP ribose) polymerase
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tional regulators [21,22]. We found that Zic2 is phosphorylated
by DNA-PKcs, and dephosphorylation decreases the protein–
protein interaction between Zic2 and RHA [8]. On the basis of
these results, we propose that phosphorylation-dependent
interaction occurs in transcriptional regulation.
In this study, we identiﬁed the DNA-PKcs target residue in
Zic2, and evaluated the role of phosphorylation by generating
a substitution mutation of the target residue.2. Materials and methods
2.1. Cell lines
293T and NIH3T3 cells were maintained in Dulbeccos modiﬁed
Eagles medium (DMEM) supplemented with 10% fetal bovine serum
(FBS). Oli-neu cells [23] were cultured in DMEM/F12 containing
15% FBS and 1% horse serum. Transfections were carried out as
described [8].2.2. Plasmid construction
We used N-terminal double-tagged (FLAG and HA) Zic2 expression
plasmid (pCMV-F-HA-Zic2) [8]. The Zic2 N-terminal truncation
mutant expression vector pCMV-F-HA-Zic2(125–531) was constructed
by insertion of a cDNA fragment generated by PCR using the following
primers (5 0-GCGGATCCGGGCTTCGGGGACTCGGCGCCG-3 0,
5 0-GCGAATTCCTCACACGTACCATTCATTGAA-3 0) between the
BamHI and EcoRI sites of pCMV-F-HA empty plasmid. pCMV-F-
HA-Zic2(181–531) and pCMV-F-HA-Zic2(201–531) were constructed
from a cDNA fragment generated by PCR using the following primers
(5 0-AAAGGATCCCATGCGCCTAGGGCTGCCGGGCGAGG-3,
5 0-AAAGGATCCCCCGCGGACCGACCCCTACTCGGCG-3 0, 5 0-
AAACTCGAGTCACACGTACCATTCATTGAAGTTGGAGG-3 0)
cloned between the BamHI and XhoI sites of pCMV-F-HA empty plas-
mid. Zic2 point-mutant expression plasmids (pCMV-F-HA-Zic2S192A
and pCMV-F-HA-Zic2S200A) were constructed by insertion of a
mutated fragment ampliﬁed by PCR using the following primers
(5 0-TTAACCCTCACTAAAGGGAACAAAAGCTGGAGCTCC-3 0,
5 0-GGGTCGATCCACTTGCAGATGAGC-3 0, S192A: 5 0-TTCGG-
GCGCGCGGAGCAATACCGC-3 0 and 5-TTGGCGGTATTGCT-
CCGCGCGCCC-3 0, S200A: 5 0-CAAGTGGCCGCCCCGCGGACC-
GAC-3 0 and5 0-GGGGTCGGTCCGCGGGGTGGCCAC-3 0) between
two SacI sites of pCMV-F-HA-Zic2. S200A mutant constructs pHM6-
Zic2S200A and pEF-Zic2S200A were constructed by insertion of an
EcoRI fragment of pCMV-F-HA-Zic2S200A into pHM6 (Roche) and
pEFBOS [24] vectors.2.3. Protein puriﬁcation
F-HA-Zic2 and its mutants were overproduced in 293T cells
transfected with expression vectors [pCMV-F-HA-Zic2, pCMV-F-
HA-Zic2(181–531), pCMV-F-HA-Zic2(125–531), pCMV-F-HA-Zic2-
(201–531), pCMV-F-HA-Zic2S192A, or pCMV-F-HA-Zic2S200A].
The proteins were aﬃnity puriﬁed by anti-FLAG and anti-HA agarose
beads (Sigma) as described [8]. Dephosphorylated Zic2 protein was
prepared using calf intestinal alkaline phosphatase (CIP) as described
[8].blished by Elsevier B.V. All rights reserved.
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Aﬃnity-puriﬁed Zic2 and mutant proteins were mixed with DNA-
PK, [c-32P] ATP, plasmid DNA, and PARP protein (to enhance the
DNA-PK activity [8]) After the reaction, proteins were separated by
SDS–PAGE and analyzed by a PhosphorImager (Fuji) as described
[8].Fig. 1. Identiﬁcation of Zic2 phosphorylation. (A) Zic2 structure and alig
Accession No. BAA11115), human (Homo sapiens, NP_009060), opossum (
laevis, AB009565), puﬀerﬁsh (Tetraodon nigroviridis, CAG07295), and zebraﬁ
acid residue among the ﬁve sequences; box in the alignment, the position of ser
of the last residue in each sequence. (B) N-terminally truncated Zic2 mutant
produced in 293T cells with N-terminal FLAG and HA tags, and aﬃnity pu
proteins were incubated with [c32P] ATP, PARP DNA-PK and plasmid DN
Zic2(201–531) was not. DNA-PKcs, Ku70, and PARP were also phosphoryla
mutant were produced in 293T cells and aﬃnity puriﬁed. (E) In vitro phosph
Zic2S192A were phosphorylated, but Zic2S200A was not. Thus, Zic2 S200 is2.5. Co-immunoprecipitation assay
Co-immunoprecipitation was performed as described [8]. 293T
cells were transfected with pHM6, pHM6-HA-Zic2, or pHM6-
HA-Zic2S200A. After 24 h, whole-cell extracts were prepared
and used for immunoprecipitation. HA-tagged proteins were immu-
noprecipitated with anti-HA agarose beads (Sigma), RHA wasnment of the phosphorylated regions of the mouse (Mus musculus,
Monodelphis domestica, ENSMODP00000036683), Xenopus (Xenopus
sh (Danio rerio, NP_571633) sequences. Asterisk, the conserved amino
ine 200 (S200) in mouse Zic2; number in parenthesis, amino acid number
proteins. To identify the Zic2 phosphorylation site, the mutants were
riﬁed. (C) In vitro phosphorylation assay. Wild-type Zic2 and mutant
A. Zic2, Zic2(125–531) and Zic2(181–531) were phosphorylated, but
ted in a DNA-dependent manner. (D) The Zic2S192A and Zic2S200A
orylation assay of Zic2, Zic2S192A and Zic2S200A proteins. Zic2 and
the target residue for DNA-PKcs-dependent phosphorylation of Zic2.
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Sepharose beads (GE Healthcare), then analyzed by Western blot-
ting analysis.2.6. Gel shift assay
A duplex DNA probe containing a Gli/Zic-binding site (GBS) was
prepared by annealing of IRD700 (LI-COR) end-labeled synthesized
DNA (5 0-IRD700-CGTCTTGGGTGGTCTCCCTC-3 0, 5 0-IRD700-
GAGGGAGACCACCCAAGACG-3 0). Aﬃnity-puriﬁed proteins (F-
HA-Zic2 or F-HA-Zic2S200A), 1.25–10 pmol were incubated with
the duplex DNA probe and analyzed by 4% native polyacrylamide
gel electrophoresis as described [8].2.7. Luciferase reporter assay
Luciferase reporter assays were carried out as described [8]. Lucifer-
ase reporter plasmid pSV40 [6] (100 ng) was cotransfected with pEF-
BOS, pEFBOS-Zic2, or pEFBOS-Zic2S200A (100 ng) and pEF-RL
[8] (2.5 ng). Luciferase activity was measured according to the manu-
facturers recommendations (Promega).2.8. Immunoﬂuorescence staining
NIH3T3 cells were transfected with pHM6-HA-Zic2 or pHM6-HA-
Zic2S200A plasmid. After 24 h, cells were analyzed by immunoﬂuores-
cence staining, as described [7].2.9. Anti-Zic2pS200 antibody
The antibody was developed in rabbit using a synthetic peptide that
includes a phosphorylated site at S200 (CYRQVApSPRTD). Antibod-
ies that recognize dephosphorylated Zic2 were eliminated with syn-
thetic peptide (CYRQVASPRTD)-conjugated Thiopropyl Sepharose
6B beads (GE Healthcare).Fig. 2. A mutation of Zic2 impairs the Zic2–RHA interaction. 293T
cells were transfected with empty vector (pHM6), HA-Zic2, or HA-
Zic2S200A expression vector. The transfected cell lysates were
subjected to immunoprecipitation (IP) assays and immunoblotting
with the indicated with the antibodies. (A) Immunoprecipitation using
anti-HA aﬃnity beads. Co-immunoprecipitated RHA, TBP and TFIIB
were decreased when Zic2S200A was used. (B) An immunoprecipita-
tion assay was carried out with anti-RHA antiserum (anti-RHA) or
control serum (pre-immune). Zic2, but not Zic2S200A was co-immu-
noprecipitated.3. Results and discussion
3.1. Identiﬁcation of a Zic2 phosphorylation site
To determine the exact site of Zic2 phosphorylation by
DNA-PK, we constructed N-terminally truncated mutants
Zic2(125–531), Zic2(181–531) and Zic2(201–531) expression
vectors (Fig. 1A). Produced proteins were aﬃnity-puriﬁed
(Fig. 1B). FLAG-HA-tagged (F-HA-) wild-type Zic2 or trun-
cated Zic2 was incubated with DNA-PK, plasmid DNA,
[c-32P] ATP and PARP, which enhances the Zic2 phosphoryla-
tion by DNA-PK. The reaction mixtures were separated by
SDS–PAGE and analyzed by PhosphorImager (Fig. 1C).
F-HA-Zic2, F-HA-Zic2(125–531) and F-HA-Zic2(181–531)
proteins were phosphorylated, but F-HA-Zic2(201–531) was
not. This result indicates that the phosphorylation site lies
between amino acids 181 and 201. This region contains two
serine residues (S192 and S200) and no threonine residues
(Fig. 1A bottom). To further analyze which serine residue is
phosphorylated, we constructed point-mutant expression
vectors for each and produced F-HA-Zic2S192A and F-HA-
Zic2S200A in mammalian cells (Fig. 1D). An in vitro phos-
phorylation assay indicated that F-HA-Zic2S192A was clearly
phosphorylated, but F-HA-Zic2S200A was not (Fig. 1E).
Thus, Zic2 is phosphorylated by DNA-PKcs on the serine res-
idue at position 200 (Zic2 S200) in vitro.
Interestingly, the sequences surrounding Zic2S200 are not
similar to the previously identiﬁed DNA-PK recognition
sequences P-S/T-X and X-S/T-Q [25]. However, this residue
is well conserved in mammals (Homo, Mus, Monodelphis),
amphibians (Xenopus), and teleost ﬁshes (Danio, Tetraodon)
(Fig. 1A bottom). Whether the Zic2 phosphorylation site is
conserved in other vertebrates will require further work.3.2. Phosphorylation-dependent protein–protein interaction
between Zic2 and RHA
Phosphatase-treatment of Zic2 inhibits the interaction
between Zic2 and RHA proteins [8]. To determine the role of
Zic2S200 phosphorylation, we performed co-immunoprecipita-
tion assays with HA-Zic2 and HA-Zic2S200A. Both co-immu-
noprecipitated DNA-PKcs, Ku70/80 heterodimer, RHA,
PARP, and TFIIB as reported previously [8], but HA-Zic2-
S200A co-immunoprecipitated less RHA, TBP (TATA-binding
protein) and TFIIB (Fig. 2A lanes 5, 6). To conﬁrm this, we
co-immunoprecipitated HA-Zic2 and HA-Zic2S200A with
anti-RHA antibody. We observed a signiﬁcant association with
A. Ishiguro, J. Aruga / FEBS Letters 582 (2008) 154–158 157HA-Zic2 (Fig. 2B lane 2) but not with preimmune serum (lane
4). In contrast, HA-Zic2S200A was less abundant in these
immunoprecipitates (lane 3). Taken together, these results sug-
gest that Zic2S200 is important for physical association with
RHA.
3.3. Eﬀect of the Zic2 S200A mutation on transcriptional
regulation
To characterize the eﬀect of the S200A mutation on Zic2
function, we probed its DNA-binding aﬃnity and subcellular
localization. Its DNA-binding aﬃnity was assessed using a
gel shift assay with puriﬁed F-HA-Zic2 and F-HA-Zic2S200A.
Zic2 and Zic2S200A bound GBS with the same aﬃnity
(Fig. 3A). When F-HA-Zic2 and F-HA-Zic2S200A were pro-
duced in NIH3T3 cells, both proteins were localized in the nu-
cleus (Fig. 3B). These results suggest that the S200A mutation
does not aﬀect the DNA-binding aﬃnity or subcellular locali-
zation of Zic2.
We then examined the transcriptional regulatory activity of
Zic2S200A. Oli-neu, an oligodendroglial precursor cell line
was transfected with Zic2 or Zic2S200A expression vectors
(pEF-Zic2 and pEF-Zic2S200A) and a reporter plasmid
(pSV40-Luc) whose expression is activated by Zic2 [7]. We
found that transcriptional activation by Zic2S200A was signif-
icantly lower than that of wild-type Zic2 (Fig. 3C). This resultFig. 3. Functional analysis of Zic2 phosphorylation. (A) Gel shift assays we
Subcellular localization by immunoﬂuorescence staining. Zic2S200A show
cells were transfected with reporter plasmid (pSV40-luc), Zic2 expression v
BOS), together with Renilla luciferase expression vector (pEF-RL). All lucif
averages and standard errors of the means of three independent experiments
of Zic2 was decreased by the S200A mutation. (D) Puriﬁed Zic2 protein w
blotting using anti-Zic2pS200 antibody. Control Zic2 protein was detectedindicates that the phosphorylation of Zic2 S200 has a func-
tional role in transcriptional regulation.
To conﬁrm that Zic2 S200 phosphorylation occurs in mam-
malian cells, we immunoblotted puriﬁed Zic2 protein from
mammalian cells with antibody raised against a phosphory-
lated Zic2 S200 peptide (Fig. 3D). Puriﬁed wild-type Zic2 pro-
tein was detectable by this antibody, but treatment of puriﬁed
Zic2 with phosphatase in vitro, prevented its detection. The re-
sult indicates that the Zic2 S200 is likely a site of phosphory-
lation in vivo.
3.4. Zic2 phosphorylation and transcriptional regulation
We have identiﬁed a Zic2 phosphorylation site and revealed
its functional signiﬁcance. Zic2 S200 may be a major phos-
phorylation target of DNA-PKcs, as indicated by mutational
analysis. The reduction of RHA-binding ability by the
S200A mutation supports our hypothesis that the transition
from Complex I (Zic2/DNAPKcs/PARP/Ku70/Ku80) to Com-
plex II (Zic2/RHA/Ku70/Ku80) depends on Zic2 phosphoryla-
tion by DNA-PKcs.
This is the ﬁrst report dealing with the functional alteration
of any Zic protein through post-translational modiﬁcation.
Further identiﬁcation and characterization of protein modiﬁ-
cations of Zic family proteins would be beneﬁcial to fully
understand their molecular function.re used to conﬁrm the DNA-binding activity of Zic2 and Zic2S200A. (B)
ed the same localization as Zic2. (C) Luciferase reporter assay. Oli-neu
ector (pEFBOS-Zic2 or pEFBOS-Zic2S200A) and empty vector (pEF-
erase activities were normalized to the activities of Renilla luciferase. The
of three samples each are shown. The transcriptional activation capacity
as dephosphorylated with CIP treatment [8], and analyzed by western
, whereas dephosphorylated Zic2 was not.
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